A Machine Learning Model With Temporal Validation for Predicting Walking Ability in Nontraumatic Spinal Cord Injury
In brief
Model predicts walking ability with 81% accuracy in a small validation cohort
Built from admission clinical measures, the model achieved 81% accuracy in a separate cohort of 37 people with nontraumatic spinal cord injury, lower than its 90% accuracy in internal testing. The retrospective results are preliminary; larger, multicenter studies are needed before the model can guide rehabilitation decisions.
- Journal
- Neurorehabilitation and neural repair (Q1)
- Published
- 16 October 2026
- Study design
- Retrospective cohort
- Evidence level
- Level 3, Low (CEBM 3b)
- Authors
- Anni Tong, Jiekai Guo, XiaoE Cai, Lifan Wang, Mengqi Chen, Yang Gao, et al.
- PMID
- 42885901
- DOI
- 10.1177/15459683261493914
Why clinicians should know about it
- Picked for Rehabilitation (paper of the day, 19 October 2026): ML model predicts walking ability in NTSCI
Abstract
BACKGROUND: Walking ability is the priority for spinal cord injury (SCI) patients. Nontraumatic SCI (NTSCI) is increasing with aging populations, yet its prognosis remains understudied. Early predictionF using admission clinical indicators could facilitate decision-making and rehabilitation planning. OBJECTIVE: To preliminarily develop and validate a machine learning model using early admission clinical indicators for predicting post-rehabilitation walking ability probability (with a classification threshold of 0.5) in patients with NTSCI. METHODS: This retrospective study included model development and temporal external validation. We enrolled 148 NTSCI patients, randomly allocating them into training (80%) and internal test (20%) sets. Four feature sets were constructed from objective clinical measures. Nine algorithms were compared; Gradient Boosting Decision Tree (GBDT) was selected based on AUC, recall, and F2-score, followed by hyperparameter tuning. The final model was validated independently on a cohort of 37 NTSCI patients (July 2025 to May 2026). Ethical approval (M202616) and consent waiver obtained; retrospectively registered (MR-11-26-021748); no patient involvement. RESULTS: The GBDT-based model outperformed all others. On internal testing, it achieved an AUC of 0.91 (95% CI: 0.77-1.00), recall 0.92 (95% CI: 0.71-1.00), and accuracy 0.90 (95% CI: 0.77-1.00). Key predictors included total lower limb muscle strength, age, and others. On temporal external validation, it showed encouraging performance with accuracy 0.81 (95% CI: 0.68-0.92) and recall 0.70 (95% CI: 0.40-1.00). CONCLUSION: This preliminary model may have potential for predicting walking ability in patients with NTSCI; however, these findings are exploratory and require confirmation in larger, multicenter cohorts before any clinical application can be considered.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.